EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z · by effect 128 graded findings

Blood sugar and weight

What human research has studied for glucose control, diabetes risk and body weight, across every ingredient in this guide, strongest evidence first. A grade describes the evidence, not a recommendation.

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. Ask a doctor or pharmacist before use, especially with medicines, in pregnancy or for a child.

Summary

How strong the evidence is

Show

Where blood sugar and weight sits on the supplement body map; colored by its strongest grade here.

Findings

Findings by ingredient

Blood sugar and weight: findings by ingredient and grade
IngredientGradeWhat was studied and found
Beta-glucan (oat and barley)ABlood glucose and insulin after meals. A 2021 meta-analysis of 103 acute crossover trial comparisons (538 participants) found adding oat beta-glucan to carbohydrate meals reduced glucose response (iAUC) by 23% and insulin by 22%; certainty was high and effects depended on dose and molecular weight. sources
Whey proteinABlood glucose after a meal (whey taken before the meal). A 2023 meta-analysis of 16 randomized crossover trials (244 individuals) found whey premeals lowered peak glucose by 1.4 mmol/L versus control (high certainty); long-term effects await future trials. sources
Alpha-lipoic acidBBody weight in adults. A 2018 meta-analysis of 12 placebo-controlled trials found slightly lower body weight (−0.69 kg) and BMI (−0.38 kg/m²) with ALA, but no significant change in waist circumference. sources
AmlaBFasting blood glucose in adults. A 2023 meta-analysis of five RCTs (3-12 weeks) found lower fasting blood glucose and improved lipids with amla; authors called for more studies. sources
BerberineBBlood glucose in type 2 diabetes. NCCIH reports some evidence of a modest blood glucose-lowering effect in people with type 2 diabetes. sources
Beta-glucan (oat and barley)BFasting glucose and HbA1c in type 2 diabetes. A 2016 meta-analysis of 4 articles (350 patients; 2.5–3.5 g/day for 3–8 weeks) found oat beta-glucan lowered fasting glucose by 0.52 mmol/L and HbA1c by 0.21%; fasting insulin did not fall significantly. sources
Bitter melonBBlood sugar control in type 2 diabetes (2019 meta-analysis). A 2019 meta-analysis of 10 studies (1,045 patients, 4–16 weeks) found single-herb preparations lowered fasting glucose (-0.72 mmol/L) and HbA1c (-0.26%) versus placebo; evidence was rated low to very low quality. sources
Bitter melonBGlucose and insulin resistance in prediabetes and type 2 diabetes (2025 meta-analysis). A 2025 meta-analysis of 25 RCTs (34 sub-studies) reported lower fasting glucose (SMD -0.46), HbA1c (SMD -0.57), insulin and HOMA-IR, with no effect on HOMA-beta. sources
Black seedBFasting glucose and HbA1c in adults. A 2024 meta-analysis of 30 randomized trials found lower fasting glucose and HbA1c but no change in insulin or HOMA-IR; heterogeneity was very high (I² over 90%). sources
Carnosine (L-carnosine)BBlood glucose and lipids. A 2020 meta-analysis of 4 RCTs (184 participants) found lower HbA1c (-0.92%) with carnosine but no significant change in fasting blood sugar, HOMA-IR, cholesterol, triglycerides or HDL-C. sources
ChromiumBBody weight and body fat. A 2019 meta-analysis (21 trials, 1,316 people, 200–1,000 mcg/day, 9–24 weeks) found about 0.75 kg more weight loss than placebo; ODS says these effects have little clinical significance. sources
Conjugated linoleic acid (CLA)BBody weight and body fat in adults. A 2024 meta-analysis of 70 RCTs (4,159 adults) found CLA lowered body mass by 0.35 kg and fat mass by 0.44 kg versus control; in high-quality trials, fat mass and body fat percentage did not change. sources
Conjugated linoleic acid (CLA)BLong-term weight in overweight and obesity. A 2012 meta-analysis of 7 RCTs lasting at least 6 months found 0.70 kg more weight loss and 1.33 kg more fat loss than placebo; the authors judged clinical relevance uncertain, and four trials had serious reporting flaws. sources
EphedraBShort-term weight loss (pre-2004 research, usually combined with caffeine). Supplements with ephedrine alkaloids, usually plus caffeine, had modest short-term effects on weight; no studies assessed long-term effects, and NCCIH states the benefit did not outweigh the serious risks. sources
Garcinia cambogiaBBody weight in adults (2011 meta-analysis). A 2011 systematic review included 12 RCTs and pooled nine: a small, statistically significant weight loss versus placebo (-0.88 kg, 95% CI -1.75 to -0.00); clinical relevance was uncertain. sources
Garcinia cambogiaBWeight, BMI, body fat and waist (2020 meta-analysis). A 2020 meta-analysis of eight RCTs (530 subjects) found lower weight (-1.34 kg), BMI (-0.99 kg/m2), percentage fat mass (-0.42%) and waist circumference (-4.16 cm) than placebo. sources
Grape seed extractBFasting glucose, lipids and inflammation markers. A 2020 meta-analysis of 50 trials reported lower fasting plasma glucose, total and LDL cholesterol, triglycerides and CRP, with no change in HbA1c, HDL cholesterol or body measurements; its abstract does not say all trials tested the extract alone. sources
GymnemaBBlood sugar in adults (randomized trials). A 2023 meta-analysis of six randomized trials found lower fasting blood sugar than control; the authors cite notable heterogeneity, low study quality and little diversity among participants. sources
Hibiscus (roselle)BFasting glucose and lipids. A 2020 meta-analysis of randomized trials found fasting glucose 3.96 mg/dL and LDL 7.84 mg/dL lower than placebo, with no significant change in total cholesterol, HDL or triglycerides. sources
Inulin and FOSBBody weight in adults. The 2024 Talukdar meta-analysis found body weight fell 0.97 kg (36 RCTs, 1,672 participants; low certainty); effects were larger in trials of 6 weeks or more and in pre-obese and obese participants. sources
Inulin and FOSBBMI, fat mass and waist circumference. A 2024 meta-analysis of 32 studies of chicory inulin-type fructans versus placebo found lower BMI (−0.39 kg/m2), fat mass (−0.37 kg) and waist circumference (−1.03 cm). Two of three authors work for a fructan producer. sources
Kelp and seaweedBBody weight and blood lipids in adults with overweight or obesity. 2025 meta-analysis of 11 trials: seaweed lowered BMI (SMD −0.40) and percent body fat, mainly with brown seaweed for at least 8 weeks, and lowered total and LDL cholesterol; no effect on glucose metabolism. sources
L-carnitineBBlood glucose control in type 2 diabetes or insulin resistance. A 2023 meta-analysis of 41 trials (about 2,900 participants) found lower fasting glucose, insulin resistance and HbA1c; ODS states larger trials are needed. sources
L-carnitineBBody weight. A 2016 meta-analysis of 9 trials (911 participants) found an average 1.33 kg greater weight loss than placebo. sources
MCT oil (medium-chain triglycerides)BBody weight and body composition in healthy adults. A 2015 meta-analysis of 13 RCTs (749 adults) found MCTs in place of long-chain triglycerides lowered body weight by 0.51 kg and reduced waist circumference and body fat; commercial bias was detected. sources
MCT oil (medium-chain triglycerides)BWeight and glucose-lipid markers in overweight or obesity. A 2024 meta-analysis found greater weight reduction with MCT-enriched than long-chain-fat diets (−1.53%), mainly with pure MCTs, and lower blood triglycerides and HOMA-IR; medium-long-chain triglyceride diets did not significantly reduce weight. sources
PomegranateBBlood glucose and insulin. A 2024 meta-analysis of 32 RCTs found small reductions in fasting glucose (-2.22 mg/dL), fasting insulin, HbA1c (-0.22%) and HOMA-IR; authors called for longer trials. sources
PomegranateBBlood glucose, insulin and HbA1c (2025 pooled analysis). A 2025 meta-analysis of 34 RCTs (1,500 participants) found lower fasting glucose (-3.04 mg/dL), insulin and HOMA-IR, but no significant change in HbA1c; authors called for longer and larger trials. sources
PropolisBBlood sugar and lipids in adults with type 2 diabetes. A 2025 meta-analysis of 12 RCTs (731 adults; 9 placebo-controlled) reported lower fasting glucose, HbA1c, HOMA-IR, LDL cholesterol and triglycerides and higher HDL; glucose and HbA1c results were heterogeneous and 6 trials were from Iran. sources
PurslaneBFasting glucose and insulin resistance. A 2023 meta-analysis of RCTs found purslane lowered fasting blood glucose (weighted mean difference -6.37) but had no significant effect on insulin, HOMA-IR or QUICKI; the authors called for higher-quality trials. sources
Resistant starchBFasting glucose and insulin resistance. A 2021 meta-analysis of 19 RCTs (excluding type 1 resistant starch and mixtures) found resistant starch lowered fasting glucose by 0.09 mmol/L and HOMA-IR by 0.33 versus digestible starch; other insulin measures did not change significantly. sources
Stinging nettleBBlood glucose in adults with type 2 diabetes (nettle supplementation). A 2020 meta-analysis of 8 RCTs (401 participants) found lower fasting blood sugar (-18.01 mg/dl) but no significant change in insulin, HOMA-IR or HbA1c; heterogeneity was high. sources
TaurineBBlood glucose, lipids and other cardiometabolic risk factors. A 2026 meta-analysis of 34 RCTs found oral taurine lowered fasting glucose (−5.90 mg/dL), HbA1c, triglycerides, total and LDL cholesterol, and systolic pressure (−4.38 mmHg); 1.5–3.0 g/day appeared more effective. sources
TocotrienolsBHbA1c, blood pressure and CRP in type 2 diabetes. A 2023 meta-analysis of 10 RCTs found tocotrienol-rich fraction (250-400 mg) lowered HbA1c (-0.23; n = 754) but did not lower systolic or diastolic blood pressure or hs-CRP. sources
White mulberry leafBFasting glucose, HbA1c and insulin in adults. A 2023 meta-analysis of 12 trials (615 participants) found mulberry leaf or leaf extract lowered fasting glucose by 0.47 mmol/L, HbA1c by 2.92 mmol/mol and fasting insulin by 0.58 μIU/mL. sources
White mulberry leafBBlood glucose after meals. A 2017 meta-analysis of 13 RCTs of Morus alba products found lower post-meal glucose at 30, 60 and 90 minutes, but no difference in fasting glucose, HbA1c or HOMA-IR. sources
Akkermansia muciniphila (pasteurized)CInsulin sensitivity and metabolic markers in overweight or obese insulin-resistant adults. In a 3-month pilot RCT (40 enrolled, 32 completed), pasteurized A. muciniphila (10^10 bacteria/day) improved insulin sensitivity (+28.6%) and lowered insulinemia and total cholesterol versus placebo; body-weight change was not significant. sources
Akkermansia muciniphila (pasteurized)CWeight regain after diet-induced weight loss. In an RCT of 90 adults with overweight or obesity, 24 weeks of pasteurized MucT after an 8-week low-energy diet led to less weight regain than placebo (1.2 vs 3.2 kg). sources
Akkermansia muciniphila (pasteurized)CBody weight and HbA1c in overweight or obese type 2 diabetes (strain AKK-WST01). In a 12-week RCT of 58 participants, live AKK-WST01 did not differ from placebo in body weight or HbA1c overall; reductions appeared only in those with low baseline A. muciniphila. It does not apply directly to pasteurized products. sources
Aloe veraCBlood sugar in people with diabetes (oral). Small studies suggest oral aloe may lower fasting blood sugar and HbA1c in people with diabetes. sources
Aloe veraCBody weight in adults with overweight or obesity and diabetes or prediabetes. One small study found a specific oral gel product taken for 8 weeks modestly reduced body weight and fat mass. sources
Aronia (black chokeberry)CFasting blood sugar and body weight. A 2026 meta-analysis of seven studies found no significant change in fasting blood sugar, body weight, BMI or waist circumference. sources
Asian ginsengCCardiometabolic measures in prediabetes and diabetes. A 2022 review of 20 studies (1,295 participants) reported improved fasting glucose and other factors, but NCCIH calls blood-sugar research overall inconclusive and conflicting. sources
AstragalusCBlood glucose in type 2 diabetes (added to metformin). A 2024 review of 20 studies (953 adults) found larger falls in fasting glucose and HbA1c with astragalus plus metformin than metformin alone; most studies were low quality with bias. sources
Baikal skullcapCGlucose tolerance in type 2 diabetes (added to metformin). A randomized placebo-controlled crossover trial (3.52 g/day, 8-week periods) in patients already on metformin reported better glucose tolerance with the root; some participants had raised liver enzymes. sources
BerberineCBody weight. Evidence comes mainly from preliminary studies with few clinical trials in people; NCCIH finds not enough rigorous evidence to judge effectiveness. sources
Bitter melonCBlood sugar control in type 2 diabetes (Cochrane review). A 2012 Cochrane review of four RCTs (479 participants, up to 3 months, generally high risk of bias) found no significant difference in glycemic control versus placebo, metformin or glibenclamide and called the evidence insufficient. sources
Bitter melonCMetabolic syndrome measures (2024 meta-analysis). A 2024 meta-analysis of nine RCTs (414 patients, 4–16 weeks) found no significant effect versus placebo on fasting glucose, HbA1c, lipids, body weight or blood pressure; statistical power was low. sources
Bitter melonCBody weight and body composition. A 2024 meta-analysis of 10 trials (448 participants) found no significant change in body weight, BMI, waist circumference or percentage body fat. sources
Bitter orangeCBody weight. Effect is unclear: studies were small with conflicting results, and most tested combination products, so bitter orange's own effect cannot be isolated. sources
Bitter orangeCWeight-loss trials reviewed systematically. A 2011 systematic review of four weight-loss trials found the efficacy evidence contradictory and weak; all reviews called for longer, rigorous, larger trials. sources
Black gingerCFasting blood glucose. A 2024 meta-analysis pooling animal studies and RCTs found lower fasting glucose in human studies (SMD -0.51, 95% CI -0.98 to -0.05). sources
BladderwrackCWeight loss alongside a reduced-calorie diet (EU traditional use). EMA's herbal committee found clinical evidence insufficient; a study of a combined preparation in obese postmenopausal women had shortcomings, such as an inadequate statistical method, so firm conclusions could not be drawn. sources
BladderwrackCBody weight and blood glucose in prediabetes (Ascophyllum plus Fucus extract). A 12-week RCT in 56 overweight or obese prediabetic adults found no effect of 500 mg/day brown-seaweed extract on body weight or blood glucose versus placebo; C-peptide and IL-6 changed slightly. sources
BladderwrackCInsulin response to a carbohydrate meal (single dose). In a crossover RCT in 23 adults, 500 mg of an Ascophyllum nodosum and Fucus vesiculosus blend before 50 g of carbohydrate lowered the insulin response by 12.1% but did not change glucose. sources
Carrageenan and agarCWeight in obese adults with impaired glucose tolerance or type 2 diabetes (agar). RCT in 76 patients: adding agar to a conventional diet for 12 weeks gave greater weight loss (−2.8 vs −1.3 kg) and total cholesterol reduction than diet alone. sources
ChromiumCBlood glucose in type 2 diabetes. A 2019 review of 58 trials found slightly lower fasting glucose and HbA1c of unclear clinical significance; a 24-week trial (137 people, 1,000 mcg/day picolinate) found no significant effect. sources
ChromiumCMetabolic syndrome. Two trials (63 people, 500 mcg twice daily, 16 weeks; 70 people, 300 mcg/day, 24 weeks) showed no meaningful benefit. sources
CinnamonCBlood sugar in type 1 or type 2 diabetes. Cochrane 2012: 10 RCTs, 577 participants, mostly cassia at a mean 2 g daily for 4 to 16 weeks; no significant HbA1c difference versus control, fasting glucose inconclusive, evidence insufficient. sources
CissusCBody weight and body fat in overweight adults. In an 8-week placebo-controlled RCT of 67 overweight adults, 300 mg/day of a stem-and-leaf extract lowered body fat and waist and hip size; the investigators' university funded the study. sources
CissusCBody weight and blood lipids in overweight and obese adults. In a placebo-controlled trial of 168 overweight or obese adults (153 completed), 300 mg/day of the same extract reduced weight, body fat, total and LDL cholesterol, triglycerides and fasting glucose. sources
CuminCBlood sugar measures in adults. A 2021 meta-analysis of 8 RCTs (552 adults) found no significant effect of cumin on fasting glucose, insulin or HOMA-IR versus placebo. sources
CuminCBlood sugar in chronic disease. A second 2021 meta-analysis of 8 controlled trials in people with chronic diseases reported lower fasting glucose and HbA1c, but no significant change in insulin. sources
Ecklonia cavaCPost-meal blood glucose in prediabetes (12 weeks). In an RCT of 80 prediabetic adults, a dieckol-rich extract (1,500 mg/day for 12 weeks) lowered postprandial glucose versus placebo; insulin and C-peptide did not differ significantly from placebo. sources
Ecklonia cavaCPost-meal blood glucose in prediabetes (single dose). In an RCT in 20 prediabetic adults, a single 600 mg dose lowered glucose at 90 and 120 minutes after a 75 g carbohydrate load, but glucose area under the curve and insulin did not differ. sources
Ecklonia cavaCGlucose and lipids across marine algal polyphenol trials. A 2018 systematic review of five trials (271 adults) found small-to-medium effects on fasting glucose, total and LDL cholesterol, but inadequate evidence to confirm consistent effects. sources
FenugreekCBlood sugar in type 2 diabetes. Some research suggests fenugreek may lower blood sugar, but many studies were not high quality; NCCIH finds not enough high-quality evidence to judge. sources
Flaxseed and flaxseed oilCBody weight in adults with overweight or obesity. One clinical trial suggests flaxseed mucilage powder mixed with water might support weight loss; flaxseed lignan extract and flaxseed oil supplements do not seem to help. sources
Flaxseed and flaxseed oilCFasting glucose and insulin resistance in gestational diabetes. Some research suggests ALA-containing flaxseed oil supplements might improve fasting measures and insulin resistance in pregnant people with gestational diabetes. sources
Flaxseed and flaxseed oilCBlood sugar control in type 2 diabetes (lignan extract). NCCIH states more research is needed on whether flaxseed lignan extract improves glycemic control or fasting blood glucose. sources
FucoidanCBlood sugar in type 2 diabetes. Crossover RCT in 30 patients: 1,620 mg/day for 12 weeks increased stool frequency; HbA1c fell slightly (6.73% to 6.59%) only in a subgroup of 14 without insulin resistance. sources
Galactooligosaccharides (GOS)CInsulin sensitivity in prediabetes. In a 12-week double-blind RCT in 44 overweight or obese prediabetic adults, 15 g/day GOS did not improve insulin sensitivity measured by hyperinsulinemic-euglycemic clamp, although it increased Bifidobacterium. sources
Garcinia cambogiaCBody weight in adults with obesity (12-week trial). In a 12-week placebo-controlled trial cited by LiverTox, 135 adults with obesity given HCA 1,500 mg daily lost a similar amount of weight as those on placebo (3.2 vs 4.1 kg). sources
Garcinia cambogiaCWeight loss overall (NCCIH assessment). NCCIH states it is unclear whether Garcinia cambogia products help with weight loss: some evidence suggests a modest effect, while other evidence shows none. sources
Garcinia cambogiaCFasting glucose, insulin and liver enzymes. A 2025 meta-analysis of nine publications (444 participants) found no significant effect on fasting blood sugar, insulin, ALT or AST compared with control groups. sources
GarlicCBlood sugar in people with diabetes. NCCIH states garlic supplements may reduce blood sugar to a small extent. sources
GlucomannanCBody weight in overweight or obese people. Pooling 8 placebo-controlled RCTs showed no statistically significant weight loss (mean difference -0.22 kg); reporting quality varied across trials. sources
GlucomannanCWeight loss (NIH ODS summary). ODS describes effects on weight as inconsistent: a 2015 review of 6 trials (293 participants, 1.24–3.99 g/day for up to 12 weeks) found no significant effect on body weight. sources
GlutathioneCInsulin sensitivity in obese men with or without type 2 diabetes. A 3-week double-blind RCT in 20 men found whole-body insulin sensitivity increased with 1,000 mg/day glutathione; markers of oxidative stress did not change. sources
GojiCBlood glucose in type 2 diabetes. MSK describes preliminary data suggesting hypoglycemic effects in type 2 diabetes and states that human studies are limited. sources
Green teaCBody weight. NCCIH reports that catechins and caffeine may have a modest effect, and that results may vary with product composition and physical activity. sources
GymnemaCGlycemic control in type 2 diabetes. A 2021 meta-analysis (10 studies, 419 participants) reported reductions in fasting and post-meal glucose and HbA1c, but compared post-treatment values with baseline rather than with a control group; heterogeneity was high. sources
GymnemaCOverall effectiveness in diabetes. LiverTox states that several human trials showed mild decreases in fasting glucose, but overall effectiveness in diabetes has not been shown. sources
HesperidinCBlood glucose control. A 2020 meta-analysis of 6 trials (318 participants) found no significant effect on fasting glucose, insulin, HbA1c, HOMA-IR or QUICKI. sources
Holy basilCBlood glucose in type 2 diabetes. A single-blind, placebo-controlled crossover trial (1996) reported fasting glucose 21.0 mg/dl and post-meal glucose 15.8 mg/dl lower with holy basil leaves than placebo leaves. sources
JujubeCBlood glucose and lipids in type 2 diabetes. In a 12-week trial in 48 adults with type 2 diabetes, 30 g/day dried jujube lowered fasting glucose, triglycerides, total and LDL cholesterol compared with control. sources
Kelp and seaweedCGlucose and lipid measures with algae and seaweed extracts. 2020 meta-analysis of 27 RCTs (1,221 participants) pooling various algae and extracts: HbA1c −0.18% and triglycerides lower, but HDL also fell and fasting glucose did not change. sources
MagnesiumCGlycemic control in type 2 diabetes. Small trials conflict: magnesium oxide or chloride improved glucose measures in some, while a 3-month trial (50 insulin-treated patients, 369 mg/day) found no effect. The ADA found not enough evidence to recommend it. sources
ManganeseCType 2 diabetes. Observational studies link both higher and lower blood manganese to diabetes, and some find no association; clinical trials in humans are lacking. sources
MangosteenCInsulin resistance in women with obesity. A 26-week randomized pilot (22 women, 20 completed) comparing behavioral therapy with or without mangosteen extract reported a significant improvement in insulin sensitivity in the mangosteen group. sources
Milk thistleCBlood sugar in type 2 diabetes. A small number of studies, mostly from Middle Eastern countries, suggest extracts may help control blood sugar; generalizability is unclear. sources
MoringaCBlood sugar, blood lipids and body weight in adults. A 2025 meta-analysis of nine randomized trials (649 participants) found no significant effect on most cardiometabolic outcomes; GRADE certainty was very low for all outcomes. sources
Myo-inositolCMetabolic and hormonal measures in PCOS. A guideline meta-analysis of 30 trials (2,230 women) found possible benefits for some metabolic measures but likely no effect on other outcomes; evidence was limited and inconclusive. sources
NeemCBlood sugar in adults with metabolic syndrome. One 12-week RCT (80 adults; 125-500 mg twice daily of a leaf-and-twig extract) reported dose-dependent improvements in fasting glucose, HbA1c and insulin resistance. sources
NMN (nicotinamide mononucleotide)CBody weight, glucose and blood lipids in adults. A meta-analysis of 15 randomized trials found no significant effects on body weight, BMI, fasting glucose, HbA1c or lipids; insulin resistance (HOMA-IR) showed a non-significant downward trend. sources
Olive leaf extractCFasting blood glucose and cardiometabolic markers. A meta-analysis of 12 RCTs (703 adults, 2 days to 12 weeks) found that fasting glucose, in studies using low doses, favored the control group; authors called for more consistent trials. sources
PotassiumCBlood glucose. Observational studies link low intake with higher diabetes risk; one small trial (29 adults with prediabetes, 40 mEq/day for 3 months) lowered fasting glucose only. sources
Prickly pearCBody weight in adults. A 2015 meta-analysis of five RCTs found no significant difference in body weight between Opuntia ficus-indica and controls (mean difference -0.83 kg, 95% CI -2.49 to 0.83); trials varied in design and reporting quality. sources
Prickly pearCBlood glucose and insulin, fruit versus cladode. A 2019 systematic review of 20 human studies found cladode and some Opuntia products mostly reduced glucose and insulin, while the fruit mostly had no significant effect; fruit and cladode studies had high risk of bias. sources
PurslaneCType 2 diabetes on one oral glucose-lowering drug. A 12-week placebo-controlled RCT (63 adults) of purslane extract found a larger systolic blood pressure drop (-7.5 vs -0.01 mmHg); HbA1c fell more only in a subgroup of responders. sources
ReishiCBlood sugar, lipids and blood pressure in type 2 diabetes. Cochrane 2015: 5 trials (398 participants). In pooled data from type 2 diabetes trials (1.4–3 g/day, 12–16 weeks), HbA1c, cholesterol, blood pressure and triglycerides did not differ from placebo; risk of bias was unclear in 4 of 5 trials. sources
Resistant starchCType 2 diabetes risk. FDA concluded there is limited credible evidence for a relationship between high-amylose maize starch (at least 50% RS2) and reduced type 2 diabetes risk; a few studies with mixed surrogate-endpoint results suggested a reduction. sources
ResveratrolCBlood sugar control in type 2 diabetes. A Cochrane review of 3 trials (50 adults; 10–1,000 mg/day for 4–5 weeks) found neutral effects on HbA1c, fasting glucose and insulin resistance; evidence was insufficient to judge efficacy or safety. sources
Royal jellyCBlood sugar markers. A 2019 meta-analysis of 5 placebo-controlled trials found no significant effect on fasting glucose (205 participants) or HbA1c (130 participants); the authors cite methodology issues and confounders such as diet. sources
SafflowerCSeed oil: blood sugar in obese postmenopausal women with type 2 diabetes. In one double-masked crossover RCT (55 enrolled, 35 completed), 8 g/day safflower oil for 16 weeks lowered HbA1c and raised HDL cholesterol. sources
SageCBlood sugar. NCCIH: there is not enough evidence to show whether sage affects blood glucose. sources
SageCBlood sugar and lipids in diabetes. A meta-analysis of 3 trials in people with diabetes reported lower fasting glucose (−31.15 mg/dL) and HbA1c (−0.94%); the authors called for stronger trials because so few exist. sources
SchisandraCBlood glucose in adults with mild hyperglycemia (omija and soybean mixture). A 12-week placebo-controlled trial in 80 adults found lower fasting and post-meal glucose with an omija-soybean extract mixture; schisandra alone was not tested. sources
Sea buckthornCBlood glucose, blood pressure and BMI. The 2022 Geng meta-analysis of 15 RCTs found no effect on blood sugar, blood pressure or body mass index. sources
SpirulinaCBody weight and body fat in adults. A 2025 meta-analysis of 17 RCTs found small reductions in body weight (-1.07 kg), BMI (-0.40) and body fat percentage (-0.84%), but no significant change in waist circumference. sources
SteviaCBlood sugar and HbA1c. The 2019 Bundgaard Anker meta-analysis found no significant effect on HbA1c and only a non-significant reduction in fasting blood glucose. sources
SumacCInsulin, glucose and body weight. In the 2025 Huang meta-analysis of 17 trials, insulin (−1.68 µU/mL), HOMA-IR and body weight (−1.03 kg) fell versus control, but fasting blood glucose did not change significantly. sources
SumacCGlycemic measures (earlier pooled analysis). A 2021 meta-analysis of 6 trials (278 participants) found no significant effect of sumac powder on fasting glucose, HbA1c, HOMA-IR or insulin. sources
Tart cherryCBlood sugar and lipids. A meta-analysis of 10 randomized trials found a small fall in fasting blood sugar (−0.51 mg/dl) and no effect on total cholesterol, triglycerides or HDL cholesterol. sources
Thiamin (vitamin B1)CDiabetes. Small studies used 150–300 mg/day thiamin and three benfotiamine trials used 120–900 mg/day; ODS states larger, longer, well-designed studies are required. sources
UbiquinolCGlucose control in type 2 diabetes. A 12-week RCT (50 patients, 100 mg/day liquid ubiquinol) reported lower HbA1c than placebo (P = 0.03) and higher catalase and glutathione peroxidase activities. sources
Vitamin K2 (menaquinone-7)CGlycemic control and blood lipids. A 2025 meta-analysis of six RCTs reported lower insulin, HbA1c and HOMA-IR with MK-7, with high heterogeneity (I2 84-87%), and no meaningful effect on other measures; authors called for higher-quality trials. sources
White mulberry leafCOverall blood sugar management (2022 review). A 2022 systematic review of RCTs found Morus alba can reduce post-meal glucose and insulin but judged the evidence insufficient to conclude it is effective for lowering blood glucose. sources
White mulberry leafCObese adults with borderline diabetes. In a 12-week randomized study, leaf powder (12 mg DNJ three times daily) lowered fasting glucose by 3.86 mg/dL and HbA1c by 0.11% from baseline; glucose tolerance did not improve. sources
ZincCType 2 diabetes and glucose measures. Meta-analyses reported improved glucose and lipid measures, but ODS concludes the evidence to date is insufficient to support any conclusions. sources
BuchuDBlood glucose, weight and blood pressure in rats. Aqueous buchu extract normalized glucose in diabetic rats, and in rats on a high-fat diet it reduced weight gain and returned diet-raised blood pressure to control values; the review authors say these results remain questionable in humans without trials. sources
ChagaDBlood sugar. Terpenoids inhibited the enzyme alpha-glucosidase in laboratory tests, and antidiabetic effects were studied in diabetic mice; not studied in people. sources
RooibosDBlood glucose in diabetic rodents. A meta-analysis of 12 rodent studies found lower blood glucose with rooibos extracts or their polyphenols, with substantial heterogeneity; no human data were included. sources
Akkermansia muciniphila (pasteurized)XWhole-body insulin sensitivity in adults with metabolic syndrome. In a double-blind placebo-controlled trial of 142 adults, 4 months of pasteurized MucT (30 billion cells/day) did not change the primary endpoint (Matsuda index); benefits appeared only in exploratory subgroups. sources
Betaine (trimethylglycine)XBody weight and body composition. A 2022 meta-analysis found betaine did not significantly change body mass, BMI, body fat percentage, fat mass or fat-free mass compared with control. sources
CalciumXBody weight and body fat. A meta-analysis of 41 RCTs (4,802 adults) found calcium supplements had no effect on weight or body fat. sources
Nicotinamide ribosideXInsulin sensitivity in obese, insulin-resistant men. A 12-week randomized trial in 40 men (2,000 mg/day) found no improvement in clamp-measured insulin sensitivity, glucose metabolism, energy expenditure or body composition. sources
Vitamin DXType 2 diabetes in prediabetes. A trial in 2,423 adults with prediabetes and overweight or obesity (4,000 IU/day D3, median 2.5 years) found no significant reduction in diabetes versus placebo. sources
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

All effect categories · All entries A–Z · Interactions

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.